10.1126/science.1241224 308 XuX.JerskeyB
It is believed that bremelanotide, as a melanocortin receptor agonist, may increase the release of dopamine in the brain, which alters key pathways involved in sexual response
~37mcg per pump ~250mcg per 1ml dropper ~150 applications per bottle
It is a worthy option for people who wish to reduce local fat accumulation or improve skin texture through non-surgical means
Digestive Slowing Motility Disorders When digestive slowing becomes excessive, patients may develop motility disorders , including: gastroparesis (stomach paralysis) ileus (functional bowel shutdown) severe constipation generalized GI dysmotility Food may: sit in the stomach for hours or days back up into the intestines cause nausea, vomiting, bloating, and pain Related: How Digestive Slowing Leads to Dehydration & Kidney Injury GLP-1-induced nausea, vomiting, and food intolerance can cause: reduced fluid intake fluid loss from vomiting/diarrhea dehydration electrolyte imbalance Dehydration can lead to: acute kidney injury worsening chronic kidney disease hospitalization or dialysis in severe cases Related: Dehydration and Kidney Damage How GLP-1 Drugs Affect the Gallbladder Rapid weight loss and altered digestion can: change bile composition reduce gallbladder emptying increase gallstone formation This can lead to: gallbladder attacks inflammation gallbladder removal surgery Related: Gallbladder Removal How GLP-1 Drugs May Contribute to Pancreatitis GLP-1 drugs affect the pancreas by: increasing insulin secretion altering pancreatic enzyme signaling In some patients, this may be associated with: pancreatic inflammation elevated enzymes acute pancreatitis Related: Pancreatitis How GLP-1 Drugs May Affect Vision (NAION) Medical experts are evaluating whether GLP-1 drugs may contribute to optic nerve ischemia , potentially through: blood pressure changes dehydration vascular perfusion changes nocturnal hypotension These mechanisms are under investigation in cases of Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) , a cause of sudden blindness
